Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study | Request PDF
Peter Garboe – Vagt – G4S | LinkedIn
Genvalg i Brabrand: Base Erhverv med ny totalentreprise